Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study

Positron emission tomography of type 2 cannabinoid receptors for detecting inflammation in the central nervous system

(2018) Ruiqing Ni et al.   ACTA PHARMACOLOGICA SINICA

Selective activation of cannabinoid receptor-2 reduces neuroinflammation after traumatic brain injury via alternative macrophage polarization

(2018) Molly Braun et al.   BRAIN BEHAVIOR AND IMMUNITY

Cellular Sources and Regional Variations in the Expression of the Neuroinflammatory Marker Translocator Protein (TSPO) in the Normal Brain

(2018) Calina Betlazar et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The Role of CB2 Receptor in the Recovery of Mice after Traumatic Brain Injury

(2018) Lital Magid et al.   JOURNAL OF NEUROTRAUMA

In vivo TSPO and cannabinoid receptor type 2 availability early in post-stroke neuroinflammation in rats: a positron emission tomography study

(2017) Teruyo Hosoya et al.   Journal of Neuroinflammation

Reconceptualization of translocator protein as a biomarker of neuroinflammation in psychiatry

(2017) T Notter et al.   MOLECULAR PSYCHIATRY

Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia

(2017) T Notter et al.   MOLECULAR PSYCHIATRY

Depiction of microglial activation in aging and dementia: Positron emission tomography with [11C]DPA713 versus [11C](R)PK11195

(2016) Masamichi Yokokura et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Combined [18F]DPA-714 micro-positron emission tomography and autoradiography imaging of microglia activation after closed head injury in mice

(2016) Ina Israel et al.   Journal of Neuroinflammation

In vivo imaging of system xc- as a novel approach to monitor multiple sclerosis

(2015) Abraham Martín et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Differential upregulation of the cannabinoid CB2 receptor in neurotoxic and inflammation-driven rat models of Parkinson's disease

(2015) Ruth M. Concannon et al.   EXPERIMENTAL NEUROLOGY

In vivo analysis of neuroinflammation in the late chronic phase after experimental stroke

(2015) H.L. Walter et al.   NEUROSCIENCE

Netrin-5 is highly expressed in neurogenic regions of the adult brain

(2015) Satoru Yamagishi et al.   Frontiers in Cellular Neuroscience

Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation

(2015) Alena V. Savonenko et al.   PLoS One

PET imaging of neuroinflammation in a rat traumatic brain injury model with radiolabeled TSPO ligand DPA-714

(2014) Yu Wang et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Radiation Dose of the P-Glycoprotein Tracer 11C-Laniquidar

(2013) A. Postnov et al.   JOURNAL OF NUCLEAR MEDICINE

Activation of the CB2 receptor system reverses amyloid-induced memory deficiency

(2012) Jiang Wu et al.   NEUROBIOLOGY OF AGING

WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway

(2012) Gohar Fakhfouri et al.   NEUROPHARMACOLOGY

Reduced infarct size and accumulation of microglia in rats treated with WIN 55,212-2 after neonatal stroke

(2012) D. Fernández-López et al.   NEUROSCIENCE

In Vivo Expression of Cyclooxygenase-1 in Activated Microglia and Macrophages During Neuroinflammation Visualized by PET with 11C-Ketoprofen Methyl Ester

(2011) M. Shukuri et al.   JOURNAL OF NUCLEAR MEDICINE

Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease

(2011) A. M. Martin-Moreno et al.   MOLECULAR PHARMACOLOGY

Preclinical evaluation of [11C]NE40, a type 2 cannabinoid receptor PET tracer

(2011) Nele Evens et al.   NUCLEAR MEDICINE AND BIOLOGY

Cannabinoid Type 2 Receptor Activation Downregulates Stroke-Induced Classic and Alternative Brain Macrophage/Microglial Activation Concomitant to Neuroprotection

(2011) Juan G. Zarruk et al.   STROKE

In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer’s disease

(2010) Masamichi Yokokura et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Morphological impairments in microglia precede age-related neuronal degeneration in senescence-accelerated mice

(2010) Sanae Hasegawa-Ishii et al.   NEUROPATHOLOGY

Multiparametric assessment of acute and subacute ischemic neuronal damage: A small animal positron emission tomography study with rat photochemically induced thrombosis model

(2010) Dai Fukumoto et al.   SYNAPSE

Synthesis and biological evaluation of carbon-11- and fluorine-18-labeled 2-oxoquinoline derivatives for type 2 cannabinoid receptor positron emission tomography imaging

(2009) Nele Evens et al.   NUCLEAR MEDICINE AND BIOLOGY

Debris clearance by microglia: an essential link between degeneration and regeneration

(2008) H. Neumann et al.   BRAIN

The CB2Cannabinoid Receptor Controls Myeloid Progenitor Trafficking

(2008) Javier Palazuelos et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Imaging Microglial Activation During Neuroinflammation and Alzheimer’s Disease

(2008) Sriram Venneti et al.   Journal of Neuroimmune Pharmacology

Cannabinoid CB2receptors in human brain inflammation

(2007) C Benito et al.   BRITISH JOURNAL OF PHARMACOLOGY